Global NK Cell Therapy Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global NK Cell Therapy market size is predicted to grow from US$ 458 million in 2025 to US$ 1164 million in 2031; it is expected to grow at a CAGR of 16.8% from 2025 to 2031.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
LPI (LP Information)' newest research report, the “NK Cell Therapy Industry Forecast” looks at past sales and reviews total world NK Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected NK Cell Therapy sales for 2025 through 2031. With NK Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global NK Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NK Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NK Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of NK Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global NK Cell Therapy market size is predicted to grow from US$ 458 million in 2025 to US$ 1164 million in 2031; it is expected to grow at a CAGR of 16.8% from 2025 to 2031.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
LPI (LP Information)' newest research report, the “NK Cell Therapy Industry Forecast” looks at past sales and reviews total world NK Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected NK Cell Therapy sales for 2025 through 2031. With NK Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global NK Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NK Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NK Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of NK Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- NK Cell Therapies
- NK Cell Directed Antibodies
- Cancer
- Gastrointestinal Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- NantWorks
- Nkarta Therapeutics
- Fortress Biotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NK Cell Therapy Market Size (2020-2031)
2.1.2 NK Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for NK Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 NK Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 NK Cell Therapy Market Size by Type
2.3.1 NK Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global NK Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 NK Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 NK Cell Therapy Market Size by Application
2.5.1 NK Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global NK Cell Therapy Market Size Market Share by Application (2020-2025)
3 NK CELL THERAPY MARKET SIZE BY PLAYER
3.1 NK Cell Therapy Market Size Market Share by Player
3.1.1 Global NK Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global NK Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global NK Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NK CELL THERAPY BY REGION
4.1 NK Cell Therapy Market Size by Region (2020-2025)
4.2 Global NK Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas NK Cell Therapy Market Size Growth (2020-2025)
4.4 APAC NK Cell Therapy Market Size Growth (2020-2025)
4.5 Europe NK Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa NK Cell Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas NK Cell Therapy Market Size by Country (2020-2025)
5.2 Americas NK Cell Therapy Market Size by Type (2020-2025)
5.3 Americas NK Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK Cell Therapy Market Size by Region (2020-2025)
6.2 APAC NK Cell Therapy Market Size by Type (2020-2025)
6.3 APAC NK Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NK Cell Therapy Market Size by Country (2020-2025)
7.2 Europe NK Cell Therapy Market Size by Type (2020-2025)
7.3 Europe NK Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NK Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa NK Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa NK Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NK CELL THERAPY MARKET FORECAST
10.1 Global NK Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global NK Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas NK Cell Therapy Forecast
10.1.3 APAC NK Cell Therapy Forecast
10.1.4 Europe NK Cell Therapy Forecast
10.1.5 Middle East & Africa NK Cell Therapy Forecast
10.2 Americas NK Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market NK Cell Therapy Forecast
10.2.2 Canada Market NK Cell Therapy Forecast
10.2.3 Mexico Market NK Cell Therapy Forecast
10.2.4 Brazil Market NK Cell Therapy Forecast
10.3 APAC NK Cell Therapy Forecast by Region (2026-2031)
10.3.1 China NK Cell Therapy Market Forecast
10.3.2 Japan Market NK Cell Therapy Forecast
10.3.3 Korea Market NK Cell Therapy Forecast
10.3.4 Southeast Asia Market NK Cell Therapy Forecast
10.3.5 India Market NK Cell Therapy Forecast
10.3.6 Australia Market NK Cell Therapy Forecast
10.4 Europe NK Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market NK Cell Therapy Forecast
10.4.2 France Market NK Cell Therapy Forecast
10.4.3 UK Market NK Cell Therapy Forecast
10.4.4 Italy Market NK Cell Therapy Forecast
10.4.5 Russia Market NK Cell Therapy Forecast
10.5 Middle East & Africa NK Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market NK Cell Therapy Forecast
10.5.2 South Africa Market NK Cell Therapy Forecast
10.5.3 Israel Market NK Cell Therapy Forecast
10.5.4 Turkey Market NK Cell Therapy Forecast
10.6 Global NK Cell Therapy Forecast by Type (2026-2031)
10.7 Global NK Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market NK Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Information
11.1.2 Nektar Therapeutics NK Cell Therapy Product Offered
11.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Nektar Therapeutics Main Business Overview
11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Information
11.2.2 Innate Pharma SA NK Cell Therapy Product Offered
11.2.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Innate Pharma SA Main Business Overview
11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
11.3.1 Affimed Company Information
11.3.2 Affimed NK Cell Therapy Product Offered
11.3.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Affimed Main Business Overview
11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Information
11.4.2 Chipscreen Biosciences NK Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Chipscreen Biosciences Main Business Overview
11.4.5 Chipscreen Biosciences Latest Developments
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Information
11.5.2 Fate Therapeutics NK Cell Therapy Product Offered
11.5.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Fate Therapeutics Main Business Overview
11.5.5 Fate Therapeutics Latest Developments
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Information
11.6.2 Glycostem Therapeutics NK Cell Therapy Product Offered
11.6.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Glycostem Therapeutics Main Business Overview
11.6.5 Glycostem Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Information
11.7.2 Dragonfly Therapeutics NK Cell Therapy Product Offered
11.7.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Dragonfly Therapeutics Main Business Overview
11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Information
11.8.2 Kiadis Pharma NK Cell Therapy Product Offered
11.8.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Kiadis Pharma Main Business Overview
11.8.5 Kiadis Pharma Latest Developments
11.9 NantWorks
11.9.1 NantWorks Company Information
11.9.2 NantWorks NK Cell Therapy Product Offered
11.9.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 NantWorks Main Business Overview
11.9.5 NantWorks Latest Developments
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Information
11.10.2 Nkarta Therapeutics NK Cell Therapy Product Offered
11.10.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Nkarta Therapeutics Main Business Overview
11.10.5 Nkarta Therapeutics Latest Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Information
11.11.2 Fortress Biotech NK Cell Therapy Product Offered
11.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Fortress Biotech Main Business Overview
11.11.5 Fortress Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. NK CellTherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. NK CellTherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NK CellTherapies
Table 4. Major Players of NK Cell Directed Antibodies
Table 5. NK CellTherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 7. Global NK CellTherapy Market Size Market Share byType (2020-2025)
Table 8. NK CellTherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global NK CellTherapy Market Size Market Share by Application (2020-2025)
Table 11. Global NK CellTherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global NK CellTherapy Revenue Market Share by Player (2020-2025)
Table 13. NK CellTherapy Key Players Head office and Products Offered
Table 14. NK CellTherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global NK CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global NK CellTherapy Market Size Market Share by Region (2020-2025)
Table 19. Global NK CellTherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global NK CellTherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas NK CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas NK CellTherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 24. Americas NK CellTherapy Market Size Market Share byType (2020-2025)
Table 25. Americas NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas NK CellTherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC NK CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC NK CellTherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 30. APAC NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe NK CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe NK CellTherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 34. Europe NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa NK CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of NK CellTherapy
Table 39. Key Market Challenges & Risks of NK CellTherapy
Table 40. Key IndustryTrends of NK CellTherapy
Table 41. Global NK CellTherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global NK CellTherapy Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global NK CellTherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global NK CellTherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. NektarTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 46. NektarTherapeutics NK CellTherapy Product Offered
Table 47. NektarTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. NektarTherapeutics Main Business
Table 49. NektarTherapeutics Latest Developments
Table 50. Innate Pharma SA Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 51. Innate Pharma SA NK CellTherapy Product Offered
Table 52. Innate Pharma SA NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Innate Pharma SA Main Business
Table 54. Innate Pharma SA Latest Developments
Table 55. Affimed Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 56. Affimed NK CellTherapy Product Offered
Table 57. Affimed NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Affimed Main Business
Table 59. Affimed Latest Developments
Table 60. Chipscreen Biosciences Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 61. Chipscreen Biosciences NK CellTherapy Product Offered
Table 62. Chipscreen Biosciences NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chipscreen Biosciences Main Business
Table 64. Chipscreen Biosciences Latest Developments
Table 65.FateTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 66.FateTherapeutics NK CellTherapy Product Offered
Table 67.FateTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68.FateTherapeutics Main Business
Table 69.FateTherapeutics Latest Developments
Table 70. GlycostemTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 71. GlycostemTherapeutics NK CellTherapy Product Offered
Table 72. GlycostemTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. GlycostemTherapeutics Main Business
Table 74. GlycostemTherapeutics Latest Developments
Table 75. DragonflyTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 76. DragonflyTherapeutics NK CellTherapy Product Offered
Table 77. DragonflyTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. DragonflyTherapeutics Main Business
Table 79. DragonflyTherapeutics Latest Developments
Table 80. Kiadis Pharma Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 81. Kiadis Pharma NK CellTherapy Product Offered
Table 82. Kiadis Pharma NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Kiadis Pharma Main Business
Table 84. Kiadis Pharma Latest Developments
Table 85. NantWorks Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 86. NantWorks NK CellTherapy Product Offered
Table 87. NantWorks NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. NantWorks Main Business
Table 89. NantWorks Latest Developments
Table 90. NkartaTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 91. NkartaTherapeutics NK CellTherapy Product Offered
Table 92. NkartaTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. NkartaTherapeutics Main Business
Table 94. NkartaTherapeutics Latest Developments
Table 95.Fortress Biotech Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 96.Fortress Biotech NK CellTherapy Product Offered
Table 97.Fortress Biotech NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98.Fortress Biotech Main Business
Table 99.Fortress Biotech Latest Developments
LIST OFFIGURES
Figure 1. NK CellTherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NK CellTherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. NK CellTherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. NK CellTherapy Sales Market Share by Country/Region (2024)
Figure 8. NK CellTherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global NK CellTherapy Market Size Market Share byType in 2024
Figure 10. NK CellTherapy in Cancer
Figure 11. Global NK CellTherapy Market: Cancer (2020-2025) & ($ millions)
Figure 12. NK CellTherapy in Gastrointestinal Diseases
Figure 13. Global NK CellTherapy Market: Gastrointestinal Diseases (2020-2025) & ($ millions)
Figure 14. NK CellTherapy in Others
Figure 15. Global NK CellTherapy Market: Others (2020-2025) & ($ millions)
Figure 16. Global NK CellTherapy Market Size Market Share by Application in 2024
Figure 17. Global NK CellTherapy Revenue Market Share by Player in 2024
Figure 18. Global NK CellTherapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 20. APAC NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 21. Europe NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 23. Americas NK CellTherapy Value Market Share by Country in 2024
Figure 24. United States NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC NK CellTherapy Market Size Market Share by Region in 2024
Figure 29. APAC NK CellTherapy Market Size Market Share byType (2020-2025)
Figure 30. APAC NK CellTherapy Market Size Market Share by Application (2020-2025)
Figure 31. China NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe NK CellTherapy Market Size Market Share by Country in 2024
Figure 38. Europe NK CellTherapy Market Size Market Share byType (2020-2025)
Figure 39. Europe NK CellTherapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 41.France NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa NK CellTherapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa NK CellTherapy Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa NK CellTherapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 54. APAC NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 55. Europe NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 57. United States NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 58. Canada NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 61. China NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 62. Japan NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 63. Korea NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 65. India NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 66. Australia NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 67. Germany NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 68.France NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 69. UK NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 70. Italy NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 71. Russia NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 74. Israel NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 75.Turkey NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 76. Global NK CellTherapy Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global NK CellTherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries NK CellTherapy Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NK Cell Therapy Market Size (2020-2031)
2.1.2 NK Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for NK Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 NK Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 NK Cell Therapy Market Size by Type
2.3.1 NK Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global NK Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 NK Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 NK Cell Therapy Market Size by Application
2.5.1 NK Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global NK Cell Therapy Market Size Market Share by Application (2020-2025)
3 NK CELL THERAPY MARKET SIZE BY PLAYER
3.1 NK Cell Therapy Market Size Market Share by Player
3.1.1 Global NK Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global NK Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global NK Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NK CELL THERAPY BY REGION
4.1 NK Cell Therapy Market Size by Region (2020-2025)
4.2 Global NK Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas NK Cell Therapy Market Size Growth (2020-2025)
4.4 APAC NK Cell Therapy Market Size Growth (2020-2025)
4.5 Europe NK Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa NK Cell Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas NK Cell Therapy Market Size by Country (2020-2025)
5.2 Americas NK Cell Therapy Market Size by Type (2020-2025)
5.3 Americas NK Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK Cell Therapy Market Size by Region (2020-2025)
6.2 APAC NK Cell Therapy Market Size by Type (2020-2025)
6.3 APAC NK Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NK Cell Therapy Market Size by Country (2020-2025)
7.2 Europe NK Cell Therapy Market Size by Type (2020-2025)
7.3 Europe NK Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NK Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa NK Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa NK Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NK CELL THERAPY MARKET FORECAST
10.1 Global NK Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global NK Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas NK Cell Therapy Forecast
10.1.3 APAC NK Cell Therapy Forecast
10.1.4 Europe NK Cell Therapy Forecast
10.1.5 Middle East & Africa NK Cell Therapy Forecast
10.2 Americas NK Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market NK Cell Therapy Forecast
10.2.2 Canada Market NK Cell Therapy Forecast
10.2.3 Mexico Market NK Cell Therapy Forecast
10.2.4 Brazil Market NK Cell Therapy Forecast
10.3 APAC NK Cell Therapy Forecast by Region (2026-2031)
10.3.1 China NK Cell Therapy Market Forecast
10.3.2 Japan Market NK Cell Therapy Forecast
10.3.3 Korea Market NK Cell Therapy Forecast
10.3.4 Southeast Asia Market NK Cell Therapy Forecast
10.3.5 India Market NK Cell Therapy Forecast
10.3.6 Australia Market NK Cell Therapy Forecast
10.4 Europe NK Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market NK Cell Therapy Forecast
10.4.2 France Market NK Cell Therapy Forecast
10.4.3 UK Market NK Cell Therapy Forecast
10.4.4 Italy Market NK Cell Therapy Forecast
10.4.5 Russia Market NK Cell Therapy Forecast
10.5 Middle East & Africa NK Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market NK Cell Therapy Forecast
10.5.2 South Africa Market NK Cell Therapy Forecast
10.5.3 Israel Market NK Cell Therapy Forecast
10.5.4 Turkey Market NK Cell Therapy Forecast
10.6 Global NK Cell Therapy Forecast by Type (2026-2031)
10.7 Global NK Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market NK Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Information
11.1.2 Nektar Therapeutics NK Cell Therapy Product Offered
11.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Nektar Therapeutics Main Business Overview
11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Information
11.2.2 Innate Pharma SA NK Cell Therapy Product Offered
11.2.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Innate Pharma SA Main Business Overview
11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
11.3.1 Affimed Company Information
11.3.2 Affimed NK Cell Therapy Product Offered
11.3.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Affimed Main Business Overview
11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Information
11.4.2 Chipscreen Biosciences NK Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Chipscreen Biosciences Main Business Overview
11.4.5 Chipscreen Biosciences Latest Developments
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Information
11.5.2 Fate Therapeutics NK Cell Therapy Product Offered
11.5.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Fate Therapeutics Main Business Overview
11.5.5 Fate Therapeutics Latest Developments
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Information
11.6.2 Glycostem Therapeutics NK Cell Therapy Product Offered
11.6.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Glycostem Therapeutics Main Business Overview
11.6.5 Glycostem Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Information
11.7.2 Dragonfly Therapeutics NK Cell Therapy Product Offered
11.7.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Dragonfly Therapeutics Main Business Overview
11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Information
11.8.2 Kiadis Pharma NK Cell Therapy Product Offered
11.8.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Kiadis Pharma Main Business Overview
11.8.5 Kiadis Pharma Latest Developments
11.9 NantWorks
11.9.1 NantWorks Company Information
11.9.2 NantWorks NK Cell Therapy Product Offered
11.9.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 NantWorks Main Business Overview
11.9.5 NantWorks Latest Developments
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Information
11.10.2 Nkarta Therapeutics NK Cell Therapy Product Offered
11.10.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Nkarta Therapeutics Main Business Overview
11.10.5 Nkarta Therapeutics Latest Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Information
11.11.2 Fortress Biotech NK Cell Therapy Product Offered
11.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Fortress Biotech Main Business Overview
11.11.5 Fortress Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. NK CellTherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. NK CellTherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NK CellTherapies
Table 4. Major Players of NK Cell Directed Antibodies
Table 5. NK CellTherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 7. Global NK CellTherapy Market Size Market Share byType (2020-2025)
Table 8. NK CellTherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global NK CellTherapy Market Size Market Share by Application (2020-2025)
Table 11. Global NK CellTherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global NK CellTherapy Revenue Market Share by Player (2020-2025)
Table 13. NK CellTherapy Key Players Head office and Products Offered
Table 14. NK CellTherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global NK CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global NK CellTherapy Market Size Market Share by Region (2020-2025)
Table 19. Global NK CellTherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global NK CellTherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas NK CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas NK CellTherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 24. Americas NK CellTherapy Market Size Market Share byType (2020-2025)
Table 25. Americas NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas NK CellTherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC NK CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC NK CellTherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 30. APAC NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe NK CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe NK CellTherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 34. Europe NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa NK CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa NK CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa NK CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of NK CellTherapy
Table 39. Key Market Challenges & Risks of NK CellTherapy
Table 40. Key IndustryTrends of NK CellTherapy
Table 41. Global NK CellTherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global NK CellTherapy Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global NK CellTherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global NK CellTherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. NektarTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 46. NektarTherapeutics NK CellTherapy Product Offered
Table 47. NektarTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. NektarTherapeutics Main Business
Table 49. NektarTherapeutics Latest Developments
Table 50. Innate Pharma SA Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 51. Innate Pharma SA NK CellTherapy Product Offered
Table 52. Innate Pharma SA NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Innate Pharma SA Main Business
Table 54. Innate Pharma SA Latest Developments
Table 55. Affimed Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 56. Affimed NK CellTherapy Product Offered
Table 57. Affimed NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Affimed Main Business
Table 59. Affimed Latest Developments
Table 60. Chipscreen Biosciences Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 61. Chipscreen Biosciences NK CellTherapy Product Offered
Table 62. Chipscreen Biosciences NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chipscreen Biosciences Main Business
Table 64. Chipscreen Biosciences Latest Developments
Table 65.FateTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 66.FateTherapeutics NK CellTherapy Product Offered
Table 67.FateTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68.FateTherapeutics Main Business
Table 69.FateTherapeutics Latest Developments
Table 70. GlycostemTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 71. GlycostemTherapeutics NK CellTherapy Product Offered
Table 72. GlycostemTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. GlycostemTherapeutics Main Business
Table 74. GlycostemTherapeutics Latest Developments
Table 75. DragonflyTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 76. DragonflyTherapeutics NK CellTherapy Product Offered
Table 77. DragonflyTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. DragonflyTherapeutics Main Business
Table 79. DragonflyTherapeutics Latest Developments
Table 80. Kiadis Pharma Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 81. Kiadis Pharma NK CellTherapy Product Offered
Table 82. Kiadis Pharma NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Kiadis Pharma Main Business
Table 84. Kiadis Pharma Latest Developments
Table 85. NantWorks Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 86. NantWorks NK CellTherapy Product Offered
Table 87. NantWorks NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. NantWorks Main Business
Table 89. NantWorks Latest Developments
Table 90. NkartaTherapeutics Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 91. NkartaTherapeutics NK CellTherapy Product Offered
Table 92. NkartaTherapeutics NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. NkartaTherapeutics Main Business
Table 94. NkartaTherapeutics Latest Developments
Table 95.Fortress Biotech Details, CompanyType, NK CellTherapy Area Served and Its Competitors
Table 96.Fortress Biotech NK CellTherapy Product Offered
Table 97.Fortress Biotech NK CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98.Fortress Biotech Main Business
Table 99.Fortress Biotech Latest Developments
LIST OFFIGURES
Figure 1. NK CellTherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NK CellTherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. NK CellTherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. NK CellTherapy Sales Market Share by Country/Region (2024)
Figure 8. NK CellTherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global NK CellTherapy Market Size Market Share byType in 2024
Figure 10. NK CellTherapy in Cancer
Figure 11. Global NK CellTherapy Market: Cancer (2020-2025) & ($ millions)
Figure 12. NK CellTherapy in Gastrointestinal Diseases
Figure 13. Global NK CellTherapy Market: Gastrointestinal Diseases (2020-2025) & ($ millions)
Figure 14. NK CellTherapy in Others
Figure 15. Global NK CellTherapy Market: Others (2020-2025) & ($ millions)
Figure 16. Global NK CellTherapy Market Size Market Share by Application in 2024
Figure 17. Global NK CellTherapy Revenue Market Share by Player in 2024
Figure 18. Global NK CellTherapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 20. APAC NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 21. Europe NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa NK CellTherapy Market Size 2020-2025 ($ millions)
Figure 23. Americas NK CellTherapy Value Market Share by Country in 2024
Figure 24. United States NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC NK CellTherapy Market Size Market Share by Region in 2024
Figure 29. APAC NK CellTherapy Market Size Market Share byType (2020-2025)
Figure 30. APAC NK CellTherapy Market Size Market Share by Application (2020-2025)
Figure 31. China NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe NK CellTherapy Market Size Market Share by Country in 2024
Figure 38. Europe NK CellTherapy Market Size Market Share byType (2020-2025)
Figure 39. Europe NK CellTherapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 41.France NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa NK CellTherapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa NK CellTherapy Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa NK CellTherapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries NK CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 54. APAC NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 55. Europe NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 57. United States NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 58. Canada NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 61. China NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 62. Japan NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 63. Korea NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 65. India NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 66. Australia NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 67. Germany NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 68.France NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 69. UK NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 70. Italy NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 71. Russia NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 74. Israel NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 75.Turkey NK CellTherapy Market Size 2026-2031 ($ millions)
Figure 76. Global NK CellTherapy Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global NK CellTherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries NK CellTherapy Market Size 2026-2031 ($ millions)
